ArticleCell insight2022

Discovery of oseltamivir-based novel PROTACs as degraders targeting neuraminidase to combat H1N1 influenza virus.

Zhichao Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.